Disrupted expression of matrix genes in the growth plate of the mouse cartilage matrix deficiency (cmd) mutant

Developmental Genetics

Volumn 22, Issue 4, 1998, Pages 349-358

  Wai, Albert W K ^d   Ng, Ling Jim ^d   Watanabe, Hideto ^a   Yamada, Yoshihiko ^a   Tam, Patrick P L ^b   Cheah, Kathryn S E ^c  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d NONE

Author keywords

Aggrecon; Cartilage matrix deficiency; Growth plate abnormal expression of matrix molecules; Mouse mutant

Indexed keywords

AGGRECAN; COLLAGEN; PROTEOGLYCAN; SYNDECAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CARTILAGE CELL; CARTILAGE MATRIX; CELL DIFFERENTIATION; CHONDRODYSPLASIA; CLEFT PALATE; CONTROLLED STUDY; DWARFISM; FETUS; GENE DISRUPTION; GENE EXPRESSION; GROWTH PLATE; HOMOZYGOTE; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL;

AGGRECANS; ANIMALS; CELL DIFFERENTIATION; CHONDROCYTES; CHROMOSOME MAPPING; EXOSTOSES, MULTIPLE HEREDITARY; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GENES, RECESSIVE; GROWTH PLATE; LECTINS, C-TYPE; MICE; MICE, MUTANT STRAINS; PROTEOGLYCANS;

ANIMALIA; MAMMALIA;

EID: 0031803529     PISSN: 0192253X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6408(1998)22:4<349::AID-DVG5>3.0.CO;2-6     Document Type: Article

References (59)

1. Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, Ling KW, Sham MH, Koopman P, Tam PP, Cheah KS (1997): SOX9 directly regulates the type-II collagen gene. Nat Genet 16:174-178.
2. Cancedda R, Cancedda FD, Castagnola P (1995): Chondrocyte differentiation. Int Rev Cytol 159:265-358.
3. Carey DJ (1997): Syndecans: Multifunctional cell-surface co-receptors. Biochem J 327:1-16.
4. Chan D, Cole WG, Chow CW, Mundlos S, Bateman JF (1995): A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage. J Biol Chem 270:1747-1753.
5. Cheah KSE, Lau ET, Au PKC, Tam PPL (1991): Expression of the mouse α1(II) collagen gene is not restricted to cartilage during development. Development 111:945-953.
6. Cheah KSE, Levy A, Trainor PA, Wai AWK, Kuffner T, So CL, Leung KKH, Lovell-Badge RH, Tam PPL (1995): Human COL2A1-directed SV40 T antigen expression in transgenic and chimeric mice results in abnormal skeletal development. J Cell Biol 128:223-237.
7. Chen Q, Johnson DM, Haudenschild DR, Goetinck PF (1995): Progression and recapitulation of the chondrocyte differentiation program: Cartilage matrix protein is a marker for cartilage maturation. Dev Biol 172:293-306.
8. Elima K, Eerola I, Rosati R, Metsäranta M, Garofalo S, Perälä M, De Crombrugghe B, Vuorio E (1993): The mouse collagen X gene: Complete nucleotide sequence, exon structure and expression pattern. Biochem J 289:247-253.
9. Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R (1996): Toward a molecular understanding of skeletal development. Cell 80:371-378.
10. Fitch JM, Mentzer A, Mayne R, Linsenmayer TF (1988): Acquisition of type IX collagen by the developing avian primary corneal stroma and vitreous. Dev Biol 128:396-405.
11. Gould SE, Upholt WB, Kosher RA (1992): Syndecan 3: A member of the syndecan family of membrane-intercalated proteoglycans that is expressed in high amounts at the onset of chicken limb cartilage differentiation. Proc Natl Acad Sci USA 89:3271-3275.
12. Hayashi M, Hayashi K, Iyama K, Trelstad RL, Linsenmayer TF, Mayne R. (1992): Notochord of chick embryos secretes short-form type IX collagen prior to the onset of vertebral chondrogenesis. Dev Dyn 194:169-176.
13. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pinnentel E, Sammarin Y, Wendel M, OldbergA, Heinegård D (1998): Cartilage matrix proteins: an acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 267:6132-6136.
14. Horton WA, Hecht JT (1993): The chondrodysplasias. In Royce PM, Steinmann B (eds): "Connective Tissue and its Heritable Disorders, Molecular Genetic and Medical Aspects." New York: Wiley-Liss, pp 641-675.
15. Kimata K, Barrach H-J, Brown KS, Pennypacker JP (1981): Absence of proteoglycan core protein in cartilage from the cmd/cmd (cartilage matrix deficiency) mouse. J Biol Chem 256:6961-6968.
16. Kimata K, Takeda M, Suzuki S, Pennypacker JP, Barrach HJ, Brown KS (1983): Presence of link protein in cartilage from cmd/cmd (cartilage matrix deficiency) mice. Arch Biochem Biophys 226:506-516.
17. Kobayakawa M, Iwata H, Brown KS, Kimata K (1985): Abnormal collagen fibrillogenesis in epiphyseal cartilage of CMD (cartilage matrix deficiency) mouse. Coll Rel Res 5:137-147.
18. Kong RYC, Kwan KM, Lau ET, Thomas JT, Boot-Handford RP, Grant ME, Cheah KSE (1993): Intron-exon structure, alternative use of promoter and expression of the mouse collagen X gene, Col10α-1. Eur J Biochem 213:99-111.
19. Koyama E, Leatherman JL, Shimazu A, Nah H-D, Pacifici M (1995): Syndecan-3, tenascin C and the development of cartilaginous skeletal elements and joints in chick limbs. Dev Dyn 203:152-162.
20. Koyama E, Shimazu A, Leatherman JL, Golden EB, Nah H-D, Pacifici M (1996): Expression of syndecan-3 and tenascin-C: possible involvement in periosteum development. J Orthop Res 14:403-412.
21. Lefebvre V, Huang W, Harley VR, Goodfellow PN, De Crombrugghe B (1997): SOX9 is a potent activator of the chondrocyte-specific enhancer of the proα1(II) collagen gene. Mol Cell Biol 17:2336-2346.
22. Li S, Prockop DJ, Helminen H, Fassler R, Lapvetelainen T, Kiraly K, PeltarriA, Arokoski J, Lui H, Arita M, Khillan JS (1995): Transgenic mice with a targeted inactivation of the Col2α1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev 9:2821-2830.
23. Li Y, Lacerda ML, Warman ML, Beier DR, Yoshioka H, Ninomiya Y, Oxford JT, Morris NP, Andrikopoulos K, Ramirez F, Wardell BB, Lifferth GD, Teuscher C, Woodward SR, Taylor BA, Seegmiller RE, Olsen BR (1995): A fibrillar collagen gene, Col11α1, is essential for skeletal morphogenesis. Cell 80:423-430.
24. Liu C, Olsen BR, Kao WWY (1993): Developmental patterns of two α1(IX) collagen mRNA isoforms in mouse. Dev Dyn 198:150-157.
25. Lui VCH, Ng LJ, Nicholls J, Tam PPL, Cheah KSE (1995): Tissue-specific and differential expression of alternatively spliced α1(II) collagen mRNAs in early human embryos. Dev Dyn 203:198-211.
26. Lui VCH, Ng LJ, Sat EWY, Nicholls J, Cheah KSE (1996): Extensive alternative splicing within the amino-propeptide coding domain of α2(XI) procollagen mRNAs. Expression of transcripts encoding truncated pro-alpha chains. J Biol Chem 271:16945-16951.
27. Maddox BK, Garofalo S, Smith C, Keene DR, Horton WA (1997): Skeletal development in transgenic mice expressing a mutation at Gly574Ser of type II collagen. Dev Dyn 208:170-177.
28. Mundlos S, Chan D, McGill J, Bateman JF (1996): An α1(II) Gly913 to cys substitution prevents the matrix incorporation of type II collagen which is replaced with type I and III collagens in cartilage from a patient with hypochondrogeneis. Am J Med Genet 63:129-136.
29. Mundlos S, Olsen BR (1997a): Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J 11:125-132.
30. Mundlos S, Olsen BR (1997b): Heritable diseases of the skeleton. Part II; Molecular insights into skeletal development-matrix components and their homeostasis. FASEB J 11:227-233.
31. Mundlos S, Zabel B (1994): Developmental expression of human cartilage matrix protein. Dev Dyn 199:241-252.
32. Muragaki M, Nishimura I, Henney A, Ninomiya Y, Olsen BR (1990): The α1(IX) collagen gene gives rise to two different transcripts in both mouse embryonic and human fetal RNA. Proc Natl Acad Sci USA 87:2400-2404.
33. Muratoglu S, Bachrati C, Malpeli M, Szabó P, Neri M, Dozin B, Deak F, Cancedda R, Kiss I (1995): Expression of the cartilage matrix protein gene at different chondrocyte developmental stages. Eur J Cell Biol 68:411-418.
34. Ng LJ, Tam PPL, Cheah KSE (1993): Preferential expression of alternatively spliced mRNAs encoding type II procollagen with a cysteine-rich amino-propeptide in differentiating cartilage and non-chondrogenic tissues during early mouse development. Dev Biol 159:403-417.
35. Ng LJ, Wheatley SC, Muscat GEO, Conway-Campbell J, Bowles J, Wright EM, Bell DM, Tam PPL, Cheah KSE, Koopman P (1997): SOX9 binds DNA, activates transcription and co-expresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183:108-121.
36. Nishimura I, Muragaki Y, Olsen BR (1989): Tissue-specific forms of type IX collagen-proteoglycan arise from the use of two widely separated promoters. J Biol Chem 264:20033-20041.
37. Olsen BR (1997): Collagen IX. Int J Biochem Cell Biol 29:555-558.
38. Oxford JT, Doege KJ, Morris NP (1995): Alternative exon splicing within the amino-terminal nontriple-helical domain of the rat pro-α1(XI) collagen chain generates multiple forms of the mRNA transcript which exhibit tissue-dependent variation. J Biol Chem 270:9478-9485.
39. Pace JM, LiY, Seegmiller RE, Teuscher C, Taylor BA, Olsen BR (1997): Disproportionate Micromelia (Dmm) in mice caused by a mutation in the C-propeptide coding region of Col2α1. Dev Dyn 208:25-33.
40. Pacifici M (1994): Tenascin-C and the development of articular cartilage. Matrix Biol 14:689-698.
41. Rittenhouse E, Dunn LC, Cookingham J, Calo C, Spiegelman M, Dooher GB, Bennett D (1978): Cartilage matrix defiecency (cmd) a new autosomal recessive lethal mutation in the mouse. J Embryol Exp Morphol 43:71-84.
42. Sandell LJ, Morris N, Robbins JR, Goldring MB (1991): Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: Differential expression of the amino-propeptide. J Cell Biol 114:1307-1319.
43. Sandell LJ, Nalin AM, Reife RA (1994a): Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development. Dev Dyn 199:129-140.
44. Sandell LJ, Sugai JV, Trippel SB (1994b): Expression of collagens I, II, X, and XI and aggrecan mRNAs by bovine growth plate chondrocytes in situ. J Orthop Res 12:1-14.
45. Savontaus M, Metsranta M, Vuorio E (1996): Retarded skeletal development in transgenic mice with a type II collagen mutation. Am J Pathol 149:2169-2182.
46. Seghatoleslami MR, Kosher RA (1996): Inhibition of in vitro limb cartilage differentiation by syndecan-3 antibodies. Dev Dyn 207:114-119.
47. Shen Z, Heinegård D, Sommarin Y (1995): Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development. Matrix Biol 14:773-781.
48. Svoboda KK, Nishimura I, Sugrue SP, Ninomiya Y, Olsen BR (1988): Embryonic chicken cornea and cartilage synthesize type IX collagen molecules with different amino-terminal domains. Proc Natl Acad Sci USA 85:7496-7500.
49. Swiderski RE, Solursh M (1992a): Differential co-expression of long and short form type IX collagen transcripts during avian limb chondrogenesis in ovo. Development 115:169-179.
50. Swiderski RE, Solursh M (1992b): Localization of type II collagen, long form α1(IX) collagen, and short form α1(IX) collagen transcripts in the developing chick notochord and axial skeleton. Dev Dyn 194:118-127.
51. Tsumaki N, Kimura T (1995): Differential expression of an acidic domain in the amino-terminal propeptide of mouse pro-α2(XI) collagen by complex alternative splicing. J Biol Chem 270:2372-2378.
52. Vertel BM (1995): The ins and outs of aggrecan. Trends Cell Biol 5:458-464.
53. Vornehm SI, Dudhia J, Von der Mark K, Aigner T (1996): Expression of collagen types IX and XI and other major cartilage matrix components by human fetal chondrocytes in Vivo. Matrix Biol 15:91-98.
54. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ (1996): Regulation of rate of cartilage differentiation by indian hedgehog and PTH-related protein. Science 273:613-622.
55. Wallis GA (1996): Bone growth: Coordinating chondrocyte differentiation. Curr Biol 6:1577-1580.
56. Watanabe H, Kimata K, Line S, Strong D, Gao L, Kozak CA, Yamada Y (1994): Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nature Genet 7:154-157.
57. Watanabe H, Nakata K, Kimata K, Nakanishi I, Yamada Y (1997): Dwarfism and age-related spinal degeneration of heterozygote cmd mice defective in aggrecan. Proc Natl Acad Sci USA 94:6943-6947.
58. Zhao Q, Eberspaecher H, Lefebvre V, De Crombrugghe B (1997): Parallel expression of Sox9 and Col2α1 in cells undergoing chondrogenesis. Dev Dyn 209:377-386.
59. Zhidkova NI, Justice SK, Mayne R (1995): Alternative mRNA processing occurs in the variable region of the pro-α1(XI) and pro-α2(XI) collagen chains. J Biol Chem 270:9486-9493.